Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Peverill

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Agreement between coronary flow velocity reserve and stress echocardiography in intermediate-severity coronary stenosesS J Duffy, J S Gelman, R E Peverill, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysisH J Teede, B P McGrath, J J Smolich, et al.
Clinical Science (London, England : 1979)|June 21, 2001
Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VIIR E Peverill, H J Teede, J J Smolich, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Agreement between coronary flow velocity reserve and stress echocardiography in intermediate-severity coronary stenosesS J Duffy, J S Gelman, R E Peverill, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysisH J Teede, B P McGrath, J J Smolich, et al.
Clinical Science (London, England : 1979)|June 21, 2001
Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VIIR E Peverill, H J Teede, J J Smolich, et al.
Pageof 2